Australian research reported by multiple outlets finds little to no evidence that many commonly marketed, additional “extras” used alongside IVF improve the odds of live birth. The studies reviewed or analysed fertility “add-ons” that are typically sold to patients at extra cost and are often promoted as improving outcomes such as implantation, pregnancy rates, or live birth. Across coverage, the finding is consistent: most of the expensive add-ons do not show a clear benefit, or there is insufficient evidence to support claims that they increase the likelihood of a live birth. The reports note that a majority of women undergoing IVF tend to pay for these optional extras, even though the evidence base for many of them appears weak. The research therefore raises questions about the value of paying additional fees for interventions when reliable data do not demonstrate improved outcomes. The outlets present the conclusion as an assessment of available evidence rather than a claim that IVF itself is ineffective, focusing specifically on the questioned add-on treatments.